TIMP2 and cancer: In contrast, when NF-κB translocation and transcriptional activity are inhibited, the expression of MMP2 and MMP9 is reduced and the expression of TIMP-2 is increased, further inhibiting the migration of cancer cells (Hsieh et al., 2017; Jin et al., 2021).